--- title: "投资者通知：Robbins LLP 通知投资者 Nano-X Imaging Ltd. 的集体诉讼" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/289650303.md" description: "Robbins LLP 宣布对 Nano-X Imaging Ltd. (NNOX) 提起集体诉讼，针对在 2025 年 3 月 31 日至 2026 年 4 月 17 日期间购买股票的投资者。诉讼指控该公司误导投资者关于制造效率和财务健康状况，隐瞒了高现金消耗和重组需求。在 2025 年第四季度财报公布后，显示出重大亏损和首席财务官离职，NNOX 股票下跌了 24.39%。投资者可以以风险代理的方式加入此案" datetime: "2026-06-13T01:17:43.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/289650303.md) - [en](https://longbridge.com/en/news/289650303.md) - [zh-HK](https://longbridge.com/zh-HK/news/289650303.md) --- # 投资者通知：Robbins LLP 通知投资者 Nano-X Imaging Ltd. 的集体诉讼 **Investor Notice: Robbins LLP Informs Investors of the Nano-X Imaging Ltd. Class Action Lawsuit** Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Nano-X Imaging Ltd. (NASDAQ: NNOX) securities between March 31, 2025 and April 17, 2026. Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. **The Allegations:** Robbins LLP is Investigating Allegations that Nano-X Imaging Ltd. (NNOX) Misled Investors Regarding Its Manufacturing Operations and Financial Condition According to the complaint, during the class period, defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) defendants overstated purported efficiency gains achieved in Nano- X’s operations, as well as the purported increased demand for its products; (ii) in reality, Nano-X’s production and manufacturing operations were poorly aligned with demand for the Company’s products; (iii) as a result, Nano-X was experiencing significantly increased operating expenses and cash burn; (iv) the foregoing significantly increased the likelihood that Nano-X would be forced to take disruptive remedial measures with respect to its manufacturing operations, entailing significant restructuring and impairment charges; and (v) as a result, defendants’ public statements were materially false and misleading at all relevant times. Plaintiff alleges that on April 20, 2026, when Nano-X issued a press release announcing its fourth quarter (“Q4”) 2025 financial results and business updates. Therein, Nano-X reported, inter alia, a Q4 net loss of $33.4 million, mainly due to a $17.5 million charge attributed to impairment of long-lived following a restructuring initiative at its Korean chip manufacturing facility. In explaining the restructuring charge, the press release acknowledged that Nano-X needed to “shift\[\] to a more efficient outsourced production model that is better aligned with current and anticipated demand.” The same press release also announced that Nano-X’s then-Chief Financial Officer (“CFO”), Defendant Ran Daniel (“Daniel”), would step down as CFO, effective July 31, 2026. On this news, the price of Nano-X’s stock price fell $0.695 per share, or 24.39%, to close at $2.155 per share on April 20, 2026. **What Now**: You may be eligible to participate in the class action against Nano-X Imaging Ltd. Shareholders who wish to serve as lead plaintiff for the class should contact Robbins LLP. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. _**All representation is on a contingency fee basis. Shareholders pay no fees or expenses.**_ **About Robbins LLP**: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Nano-X Imaging Ltd. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome. Aaron Dumas, Jr. Robbins LLP 5060 Shoreham Pl., Ste. 300 San Diego, CA 92122 adumas@robbinsllp.com (800) 350-6003 www.robbinsllp.com View source version on businesswire.com: https://www.businesswire.com/news/home/20260612279863/en/ ### 相关股票 - [NNOX.US](https://longbridge.com/zh-CN/quote/NNOX.US.md) ## 相关资讯与研究 - [Nano-X Imaging（纳斯达克代码：NNOX）公布财务业绩](https://longbridge.com/zh-CN/news/283363756.md) - [DualityBio Ltd.增持映恩生物-B1 万股 每股作价 173.778 港元](https://longbridge.com/zh-CN/news/289317634.md) - [TechCreate Group Ltd. 发布声明回应纽约证券交易所退市程序 | TCGL 股票新闻](https://longbridge.com/zh-CN/news/289642678.md) - [Canagold Resources Ltd. 宣布年度股东大会的投票结果 | CRCUF 股票新闻](https://longbridge.com/zh-CN/news/289643793.md) - [AFLAC（纽约证券交易所代码：AFL）的主要股东日本 Post Holdings Co. Ltd. 出售了 26,500 股股票](https://longbridge.com/zh-CN/news/289616683.md)